What is the current Price Target for the Portage Biotech Inc stock?

The average Portage Biotech Inc target price is $7.14. This is 317.54% higher than the current stock price. The highest price target is 329.82%, the lowest is 313.45%. 3 Analysts have issued a price target Portage Biotech Inc 2026 .

How high will the Portage Biotech Inc stock rise?

No reliable answer can be given as to how high the Portage Biotech Inc stock will rise. The performance of stocks, including the Portage Biotech Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Portage Biotech Inc stock today?

The performance of Portage Biotech Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Portage Biotech Inc stock fall?

The decline in Portage Biotech Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Portage Biotech Inc Forecast, price target & analysts

$1.71

7.55%

Nasdaq, Thu, Dec 04 2025

ISIN

VGG7185A1286

Symbol

PRTG

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Portage Biotech Inc Target price 2025 - Analyst rating & recommendation

Portage Biotech Inc Classifications & Recommendation:

Hold

50%

Sell

50%

Portage Biotech Inc Price Target

Target Price	$7.14
Price	$1.71
Potential	317.54% register free of charge
Number of Estimates	3

	3 Analysts have issued a price target Portage Biotech Inc 2026 . The average Portage Biotech Inc target price is $7.14. This is 317.54% register free of charge higher than the current stock price. The highest price target is $7.35 329.82% register free of charge , the lowest is $7.07 313.45% register free of charge .
	A rating was issued by 6 analysts: 0 Analysts recommend Portage Biotech Inc to buy, 3 to hold and 3 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Portage Biotech Inc stock has an average upside potential 2026 of 317.54% register free of charge . Most analysts recommend the Portage Biotech Inc stock at Sell or hold.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Annually

	Mar '25	2026 Estimates
Earnings Per Share $	-5.72	-0.53
	92.66%	90.73%
P/E		negative

3 Analysts have issued a Portage Biotech Inc forecast for earnings per share. The average Portage Biotech Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2025	$-5.72	92.66%
2026	$-0.53 90.73% Unlock

Current	-0.19	211.49%
2026	-3.00 1,458.44% Unlock

Portage Biotech Inc...

Discover more stocks with a high price target

Netflix 1,273.57%

Coinbase Global, Inc. 48.88%

Adidas 48.28%

BioNTech SE - ADR 47.16%

Rheinmetall 45.71%

NIO ADR 42.52%

Deutsche Telekom 41.51%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now